This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Report From the Drug Epidemiology Unit and the Boston Collaborative Drug Surveillance Program

Chester Swett, Jr, MD

Arch Gen Psychiatry. 1975;32(11):1416-1418.

Abstract
• Phenothiazine-induced bone marrow depression (BMD) was evaluated in three separate but complementary data bases: (1) Among 1,048 patients admitted to psychiatric hospitals, there was no evidence of subclinical depression of the white blood cell (WBC) count attributable to phenothiazines used before admission. (2) Among 18,587 medical inpatients, there were 34 patients admitted for BMD in the absence of neoplasia or prior cytotoxic drug therapy; one of the latter reported using chlorpromazine hydrochloride, but it is doubtful whether this drug was the cause of the BMD. (3) Among 24,795 medical, surgical, and gynecological patients surveyed over a ten-month period in 1972, there were four who were admitted for BMD; one of the latter had a reversible leukopenia attributed to trifluoperazine hydrochloride.

Author Affiliations
From the Boston Collaborative Drug Surveillance Program, Waltham, Mass, and the Department of Psychiatry, Boston University School of Medicine. Dr Swett is now with the McLean Hospital, Belmont, Mass.

Footnotes
Accepted for publication Dec 18, 1974.

Reprint requests to the Boston Collaborative Drug Surveillance Program, 400 Totten Pond Rd, Waltham, MA 02154 (Dr Swett).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methods of assessing unwanted effects of psychotropic drugs. General considerations and overview
Edwards
J Psychopharmacol 1992;6:191-197.